▶ 調査レポート

世界の直接経口抗凝固薬市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Direct Oral Anticoagulant Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界の直接経口抗凝固薬市場 2021:企業別、地域別、種類・用途別 / Global Direct Oral Anticoagulant Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X05348資料のイメージです。• レポートコード:GIR-105X05348
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、直接経口抗凝固薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。直接経口抗凝固薬の種類別市場規模(アピキサバン、ダビガトラン、リバロキサバン、エドキサバン)、用途別市場規模(病院薬局、ドラッグストア、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・直接経口抗凝固薬の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Bristol-Meyers Squibb Co、Pfizer Inc.、Boehringer Ingelheim Pharmaceuticals, Inc、Janssen Pharmaceuticals, Inc.、Bayer AG、Teva Pharmaceutical Industries Ltd、Pab Organics Private Limited、Daiichi Sankyo Company, Limited
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:アピキサバン、ダビガトラン、リバロキサバン、エドキサバン
・用途別分析2016年-2026年:病院薬局、ドラッグストア、オンライン薬局
・直接経口抗凝固薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・直接経口抗凝固薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・直接経口抗凝固薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・直接経口抗凝固薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・直接経口抗凝固薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Direct Oral Anticoagulant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Direct Oral Anticoagulant size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Direct Oral Anticoagulant market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Direct Oral Anticoagulant market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Apixaban
Dabigatran
Rivaroxaban
Edoxaban

Market segment by Application can be divided into
Hospitals Pharmacies
Drug Stores
Online Pharmacies

The key market players for global Direct Oral Anticoagulant market are listed below:
Bristol-Meyers Squibb Co
Pfizer Inc.
Boehringer Ingelheim Pharmaceuticals, Inc
Janssen Pharmaceuticals, Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd
Pab Organics Private Limited
Daiichi Sankyo Company, Limited

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Direct Oral Anticoagulant Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Direct Oral Anticoagulant Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Apixaban
1.2.3 Dabigatran
1.2.4 Rivaroxaban
1.2.5 Edoxaban
1.3 Market Analysis by Application
1.3.1 Overview: Global Direct Oral Anticoagulant Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Global Direct Oral Anticoagulant Market Size & Forecast
1.4.1 Global Direct Oral Anticoagulant Sales in Value (2016-2026))
1.4.2 Global Direct Oral Anticoagulant Sales in Volume (2016-2026)
1.4.3 Global Direct Oral Anticoagulant Price by Type (2016-2026) & (USD/Kg)
1.5 Global Direct Oral Anticoagulant Production Capacity Analysis
1.5.1 Global Direct Oral Anticoagulant Total Production Capacity (2016-2026)
1.5.2 Global Direct Oral Anticoagulant Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Direct Oral Anticoagulant Market Drivers
1.6.2 Direct Oral Anticoagulant Market Restraints
1.6.3 Direct Oral Anticoagulant Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Meyers Squibb Co
2.1.1 Bristol-Meyers Squibb Co Details
2.1.2 Bristol-Meyers Squibb Co Major Business
2.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product and Services
2.1.4 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer Inc.
2.2.1 Pfizer Inc. Details
2.2.2 Pfizer Inc. Major Business
2.2.3 Pfizer Inc. Direct Oral Anticoagulant Product and Services
2.2.4 Pfizer Inc. Direct Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Boehringer Ingelheim Pharmaceuticals, Inc
2.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Details
2.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Major Business
2.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product and Services
2.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Janssen Pharmaceuticals, Inc.
2.4.1 Janssen Pharmaceuticals, Inc. Details
2.4.2 Janssen Pharmaceuticals, Inc. Major Business
2.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product and Services
2.4.4 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Direct Oral Anticoagulant Product and Services
2.5.4 Bayer AG Direct Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Teva Pharmaceutical Industries Ltd
2.6.1 Teva Pharmaceutical Industries Ltd Details
2.6.2 Teva Pharmaceutical Industries Ltd Major Business
2.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product and Services
2.6.4 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Pab Organics Private Limited
2.7.1 Pab Organics Private Limited Details
2.7.2 Pab Organics Private Limited Major Business
2.7.3 Pab Organics Private Limited Direct Oral Anticoagulant Product and Services
2.7.4 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Daiichi Sankyo Company, Limited
2.8.1 Daiichi Sankyo Company, Limited Details
2.8.2 Daiichi Sankyo Company, Limited Major Business
2.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product and Services
2.8.4 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Direct Oral Anticoagulant Sales by Manufacturer
3.1 Global Direct Oral Anticoagulant Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Direct Oral Anticoagulant Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Direct Oral Anticoagulant
3.4 Market Concentration Rate
3.4.1 Top 3 Direct Oral Anticoagulant Manufacturer Market Share
3.4.2 Top 6 Direct Oral Anticoagulant Manufacturer Market Share
3.5 Global Direct Oral Anticoagulant Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Direct Oral Anticoagulant Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Direct Oral Anticoagulant Market Size by Region
4.1.1 Global Direct Oral Anticoagulant Sales in Volume by Region (2016-2026)
4.1.2 Global Direct Oral Anticoagulant Revenue by Region (2016-2026)
4.2 North America Direct Oral Anticoagulant Revenue (2016-2026)
4.3 Europe Direct Oral Anticoagulant Revenue (2016-2026)
4.4 Asia-Pacific Direct Oral Anticoagulant Revenue (2016-2026)
4.5 South America Direct Oral Anticoagulant Revenue (2016-2026)
4.6 Middle East and Africa Direct Oral Anticoagulant Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Direct Oral Anticoagulant Sales in Volume by Type (2016-2026)
5.2 Global Direct Oral Anticoagulant Revenue by Type (2016-2026)
5.3 Global Direct Oral Anticoagulant Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Direct Oral Anticoagulant Sales in Volume by Application (2016-2026)
6.2 Global Direct Oral Anticoagulant Revenue by Application (2016-2026)
6.3 Global Direct Oral Anticoagulant Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Direct Oral Anticoagulant Sales by Type (2016-2026)
7.2 North America Direct Oral Anticoagulant Sales by Application (2016-2026)
7.3 North America Direct Oral Anticoagulant Market Size by Country
7.3.1 North America Direct Oral Anticoagulant Sales in Volume by Country (2016-2026)
7.3.2 North America Direct Oral Anticoagulant Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Direct Oral Anticoagulant Sales by Type (2016-2026)
8.2 Europe Direct Oral Anticoagulant Sales by Application (2016-2026)
8.3 Europe Direct Oral Anticoagulant Market Size by Country
8.3.1 Europe Direct Oral Anticoagulant Sales in Volume by Country (2016-2026)
8.3.2 Europe Direct Oral Anticoagulant Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Direct Oral Anticoagulant Sales by Type (2016-2026)
9.2 Asia-Pacific Direct Oral Anticoagulant Sales by Application (2016-2026)
9.3 Asia-Pacific Direct Oral Anticoagulant Market Size by Region
9.3.1 Asia-Pacific Direct Oral Anticoagulant Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Direct Oral Anticoagulant Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Direct Oral Anticoagulant Sales by Type (2016-2026)
10.2 South America Direct Oral Anticoagulant Sales by Application (2016-2026)
10.3 South America Direct Oral Anticoagulant Market Size by Country
10.3.1 South America Direct Oral Anticoagulant Sales in Volume by Country (2016-2026)
10.3.2 South America Direct Oral Anticoagulant Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Direct Oral Anticoagulant Sales by Type (2016-2026)
11.2 Middle East & Africa Direct Oral Anticoagulant Sales by Application (2016-2026)
11.3 Middle East & Africa Direct Oral Anticoagulant Market Size by Country
11.3.1 Middle East & Africa Direct Oral Anticoagulant Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Direct Oral Anticoagulant Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Direct Oral Anticoagulant Typical Distributors
12.3 Direct Oral Anticoagulant Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Direct Oral Anticoagulant Revenue by Type, (USD Million), 2021-2026
Table 2. Global Direct Oral Anticoagulant Revenue by Application, (USD Million), 2021-2026
Table 3. Bristol-Meyers Squibb Co Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Meyers Squibb Co Major Business
Table 5. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product and Services
Table 6. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Inc. Major Business
Table 9. Pfizer Inc. Direct Oral Anticoagulant Product and Services
Table 10. Pfizer Inc. Direct Oral Anticoagulant Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boehringer Ingelheim Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Pharmaceuticals, Inc Major Business
Table 13. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product and Services
Table 14. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Janssen Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Janssen Pharmaceuticals, Inc. Major Business
Table 17. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product and Services
Table 18. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 20. Bayer AG Major Business
Table 21. Bayer AG Direct Oral Anticoagulant Product and Services
Table 22. Bayer AG Direct Oral Anticoagulant Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Ltd Major Business
Table 25. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product and Services
Table 26. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pab Organics Private Limited Basic Information, Manufacturing Base and Competitors
Table 28. Pab Organics Private Limited Major Business
Table 29. Pab Organics Private Limited Direct Oral Anticoagulant Product and Services
Table 30. Pab Organics Private Limited Direct Oral Anticoagulant Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Daiichi Sankyo Company, Limited Basic Information, Manufacturing Base and Competitors
Table 32. Daiichi Sankyo Company, Limited Major Business
Table 33. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product and Services
Table 34. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Direct Oral Anticoagulant Sales by Manufacturer (2019-2021e) & (MT)
Table 36. Global Direct Oral Anticoagulant Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Direct Oral Anticoagulant, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Direct Oral Anticoagulant Production Capacity by Company, (MT): 2020 VS 2021
Table 39. Head Office and Direct Oral Anticoagulant Production Site of Key Manufacturer
Table 40. Global Direct Oral Anticoagulant Sales by Region (2016-2021e) & (MT)
Table 41. Global Direct Oral Anticoagulant Sales by Region (2021-2026) & (MT)
Table 42. Global Direct Oral Anticoagulant Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Direct Oral Anticoagulant Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Direct Oral Anticoagulant Sales by Type (2016-2021e) & (MT)
Table 45. Global Direct Oral Anticoagulant Sales by Type (2021-2026) & (MT)
Table 46. Global Direct Oral Anticoagulant Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Direct Oral Anticoagulant Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Direct Oral Anticoagulant Price by Type (2016-2021e) & (USD/Kg)
Table 49. Global Direct Oral Anticoagulant Price by Type (2021-2026) & (USD/Kg)
Table 50. Global Direct Oral Anticoagulant Sales by Application (2016-2021e) & (MT)
Table 51. Global Direct Oral Anticoagulant Sales by Application (2021-2026) & (MT)
Table 52. Global Direct Oral Anticoagulant Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Direct Oral Anticoagulant Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Direct Oral Anticoagulant Price by Application (2016-2021e) & (USD/Kg)
Table 55. Global Direct Oral Anticoagulant Price by Application (2021-2026) & (USD/Kg)
Table 56. North America Direct Oral Anticoagulant Sales by Country (2016-2021e) & (MT)
Table 57. North America Direct Oral Anticoagulant Sales by Country (2021-2026) & (MT)
Table 58. North America Direct Oral Anticoagulant Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Direct Oral Anticoagulant Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Direct Oral Anticoagulant Sales by Type (2016-2021e) & (MT)
Table 61. North America Direct Oral Anticoagulant Sales by Type (2021-2026) & (MT)
Table 62. North America Direct Oral Anticoagulant Sales by Application (2016-2021e) & (MT)
Table 63. North America Direct Oral Anticoagulant Sales by Application (2021-2026) & (MT)
Table 64. Europe Direct Oral Anticoagulant Sales by Country (2016-2021e) & (MT)
Table 65. Europe Direct Oral Anticoagulant Sales by Country (2021-2026) & (MT)
Table 66. Europe Direct Oral Anticoagulant Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Direct Oral Anticoagulant Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Direct Oral Anticoagulant Sales by Type (2016-2021e) & (MT)
Table 69. Europe Direct Oral Anticoagulant Sales by Type (2021-2026) & (MT)
Table 70. Europe Direct Oral Anticoagulant Sales by Application (2016-2021e) & (MT)
Table 71. Europe Direct Oral Anticoagulant Sales by Application (2021-2026) & (MT)
Table 72. Asia-Pacific Direct Oral Anticoagulant Sales by Region (2016-2021e) & (MT)
Table 73. Asia-Pacific Direct Oral Anticoagulant Sales by Region (2021-2026) & (MT)
Table 74. Asia-Pacific Direct Oral Anticoagulant Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Direct Oral Anticoagulant Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Direct Oral Anticoagulant Sales by Type (2016-2021e) & (MT)
Table 77. Asia-Pacific Direct Oral Anticoagulant Sales by Type (2021-2026) & (MT)
Table 78. Asia-Pacific Direct Oral Anticoagulant Sales by Application (2016-2021e) & (MT)
Table 79. Asia-Pacific Direct Oral Anticoagulant Sales by Application (2021-2026) & (MT)
Table 80. South America Direct Oral Anticoagulant Sales by Country (2016-2021e) & (MT)
Table 81. South America Direct Oral Anticoagulant Sales by Country (2021-2026) & (MT)
Table 82. South America Direct Oral Anticoagulant Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Direct Oral Anticoagulant Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Direct Oral Anticoagulant Sales by Type (2016-2021e) & (MT)
Table 85. South America Direct Oral Anticoagulant Sales by Type (2021-2026) & (MT)
Table 86. South America Direct Oral Anticoagulant Sales by Application (2016-2021e) & (MT)
Table 87. South America Direct Oral Anticoagulant Sales by Application (2021-2026) & (MT)
Table 88. Middle East & Africa Direct Oral Anticoagulant Sales by Country (2016-2021e) & (MT)
Table 89. Middle East & Africa Direct Oral Anticoagulant Sales by Country (2021-2026) & (MT)
Table 90. Middle East & Africa Direct Oral Anticoagulant Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Direct Oral Anticoagulant Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Direct Oral Anticoagulant Sales by Type (2016-2021e) & (MT)
Table 93. Middle East & Africa Direct Oral Anticoagulant Sales by Type (2021-2026) & (MT)
Table 94. Middle East & Africa Direct Oral Anticoagulant Sales by Application (2016-2021e) & (MT)
Table 95. Middle East & Africa Direct Oral Anticoagulant Sales by Application (2021-2026) & (MT)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Direct Oral Anticoagulant Typical Distributors
Table 99. Direct Oral Anticoagulant Typical Customers
List of Figures
Figure 1. Direct Oral Anticoagulant Picture
Figure 2. Global Direct Oral Anticoagulant Sales Market Share by Type in 2020
Figure 3. Apixaban
Figure 4. Dabigatran
Figure 5. Rivaroxaban
Figure 6. Edoxaban
Figure 7. Global Direct Oral Anticoagulant Sales Market Share by Application in 2020
Figure 8. Hospitals Pharmacies
Figure 9. Drug Stores
Figure 10. Online Pharmacies
Figure 11. Global Direct Oral Anticoagulant Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 12. Global Direct Oral Anticoagulant Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Direct Oral Anticoagulant Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Direct Oral Anticoagulant Sales (2016-2026) & (MT)
Figure 33. Global Direct Oral Anticoagulant Production Capacity (2016-2026) & (MT)
Figure 34. Global Direct Oral Anticoagulant Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Direct Oral Anticoagulant Market Drivers
Figure 36. Direct Oral Anticoagulant Market Restraints
Figure 37. Direct Oral Anticoagulant Market Trends
Figure 38. Global Direct Oral Anticoagulant Sales Market Share by Manufacturer in 2020
Figure 39. Global Direct Oral Anticoagulant Revenue Market Share by Manufacturer in 2020
Figure 40. Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Direct Oral Anticoagulant Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Direct Oral Anticoagulant Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Direct Oral Anticoagulant Sales Market Share by Region (2016-2026)
Figure 44. Global Direct Oral Anticoagulant Revenue Market Share by Region (2016-2026)
Figure 45. North America Direct Oral Anticoagulant Revenue (2016-2026) & (USD Million)
Figure 46. Europe Direct Oral Anticoagulant Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Direct Oral Anticoagulant Revenue (2016-2026) & (USD Million)
Figure 48. South America Direct Oral Anticoagulant Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Direct Oral Anticoagulant Revenue (2016-2026) & (USD Million)
Figure 50. Global Direct Oral Anticoagulant Sales Market Share by Type (2016-2026)
Figure 51. Global Direct Oral Anticoagulant Revenue Market Share by Type (2016-2026)
Figure 52. Global Direct Oral Anticoagulant Price by Type (2016-2026) & (USD/Kg)
Figure 53. Global Direct Oral Anticoagulant Sales Market Share by Application (2016-2026)
Figure 54. Global Direct Oral Anticoagulant Revenue Market Share by Application (2016-2026)
Figure 55. Global Direct Oral Anticoagulant Price by Application (2016-2026) & (USD/Kg)
Figure 56. North America Direct Oral Anticoagulant Sales Market Share by Country (2016-2026)
Figure 57. North America Direct Oral Anticoagulant Revenue Market Share by Country (2016-2026)
Figure 58. North America Direct Oral Anticoagulant Sales Market Share by Type (2016-2026)
Figure 59. North America Direct Oral Anticoagulant Sales Market Share by Application (2016-2026)
Figure 60. Europe Direct Oral Anticoagulant Sales Market Share by Country (2016-2026)
Figure 61. Europe Direct Oral Anticoagulant Revenue Market Share by Country (2016-2026)
Figure 62. Europe Direct Oral Anticoagulant Sales Market Share by Type (2016-2026)
Figure 63. Europe Direct Oral Anticoagulant Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Direct Oral Anticoagulant Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Direct Oral Anticoagulant Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Direct Oral Anticoagulant Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Direct Oral Anticoagulant Sales Market Share by Application (2016-2026)
Figure 68. South America Direct Oral Anticoagulant Sales Market Share by Country (2016-2026)
Figure 69. South America Direct Oral Anticoagulant Revenue Market Share by Country (2016-2026)
Figure 70. South America Direct Oral Anticoagulant Sales Market Share by Type (2016-2026)
Figure 71. South America Direct Oral Anticoagulant Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Direct Oral Anticoagulant Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Direct Oral Anticoagulant Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Direct Oral Anticoagulant Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Direct Oral Anticoagulant Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source